Where is BIGME located?

BIGME is headquartered in Indore, India.

Who is the current CEO of BIGME?

Arjit Jain of BIGME. They have also founded 1 company.

Is BIGME a funded company?

BIGME is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does BIGME rank among its competitors?

BIGME ranks 80th amongst 72 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Vaxxas, which secured $31.9M in Aug, 2025.

Who are the top competitors of BIGME?

BIGME's top competitors include scPharmaceuticals, Vaxxas and BioSapien. Among them, Vaxxas secured the most recent funding round in August, 2025.

BIGME - 2026 Company Profile, Team & Competitors

Company Details

Online retailer of wellness patches providing transdermal nutrient delivery. The company offers patches for workout support, anxiety relief, sleep improvement, and focus enhancement. Patches utilize transdermal technology for direct nutrient absorption through the skin. The patches are designed for convenient application and controlled release.

Website: bigme.in
Email ID: *****@bigme.in

Key Metrics

Founded Year

2024

Location

Indore, India

Stage

Unfunded

Ranked

80^th among 94 competitors

Similar Companies

scPharmaceuticals & 92 more

View BIGME's full profile

BIGME has not raised any funding rounds yet.

The founders of BIGME is Arjit Jain. Arjit Jain is the CEO of BIGME.

Here are the details of BIGME's key team members:

Arjit Jain: Co-Founder & CEO of BIGME.

View details of BIGME's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BIGME include scPharmaceuticals, Vaxxas and BioSapien. Here is the list of Top 10 competitors of BIGME, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	scPharmaceuticals 2013, Lexington (United States), Acquired	Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure	$78.7M	Orbimed, Sun Pharma & 4 others	68/100
2nd	Vaxxas 2010, Brisbane (Australia), Series D	Developer of a needle-free patch technology for vaccine delivery applications	$91.2M	One Ventures, UniQuest & 12 others	59/100
3rd	BioSapien 2018, New York City (United States), Seed	Developer of 3D-printed chip for cancer indications	$10.6M	JPIN, Global Ventures & 13 others	54/100
4th	Valeritas 2003, Bridgewater (United States), Acquired	Developer of wearable insulin patch pumps for insulin delivery through the skin	$231M	Welsh, Carson, Anderson & Stowe, Abingworth ... & 12 others	53/100
5th	Starton 2017, New York City (United States), Seed	Developer of drug delivery solution and drugs for treating oncology	$9.29M	LOVE Pharma, Goldfingr	53/100
6th	Scilex Holding 2019, Palo Alto (United States), Public	Developer of non-opioid therapies for acute and chronic pain	-	Frazier Life Sciences	52/100
7th	Corsair Phama 2014, San Francisco (United States), Series B	Developer of drugs for the treatemnt of cardiac diseases	$23M	New Rhein, Primavera & 3 others	51/100
8th	CeQur 2008, Horw (Switzerland), Series D	Developer of wearable insulin delivery patch	$392M	Endeavour Vision, Schroders & 7 others	46/100
9th	ULURU 1987, Addison (United States), Acquired	Medical technology company innovating wound care and drug delivery systems	-	-	43/100
10th	Virpax Pharmaceuticals 2016, Malvern (United States), Public	Developer of meter-dosed spray & liposomal gels for topical pain management	$1.38M	-	43/100
80th	BIGME 2024, Indore (India), Unfunded	Online retailer of wellness patches providing transdermal nutrient delivery	-	-	16/100